IRON SUCROSE

Product Description

Niksan Pharmaceutical is one of the leading Manufacturer, Exporter, Distributor, and Supplier of Iron sucrose API and finished formulation of Iron sucrose in Ankleshwar, Gujarat, India. To understand the largest accomplishment of clients, we present these products at very realistic price ranges. Niksan pharmaceutical and Niksan group companies are nowadays one of the largest manufacturer and exporter of Iron sucrose API and also finished formulations.

Niksan Pharmaceutical is one of leading manufacturer and exporter of Iron sucrose for many years in all the countries like Pakistan, Philippines, Canada, United States, Malaysia, United Kingdom ,Vietnam, Iraq, United Arab Emirates,Bangladesh, Denmark, Malaysia, Kenya, Austria, Norway, Nigeria, Hungary, Hong Kong, Saudi Arabia, Pakistan, Slovakia, Thailand, South Korea, Argentina, South Africa, Iran, Czechia, Israel, Taiwan, Greece, Egypt Romania, Netherlands,Turkey, Poland, Mexico, Spain, France, Italy, Brazil, Japan and many other countries.

Niksan Pharmaceutical provides Iron sucrose to all states of India like Punjab, Rajasthan, Andhra Pradesh, Haryana,Telangana, Bihar, Karnataka, Delhi, Tamil Nadu, Odisha, Maharashtra, WestBengal, Uttar Pradesh, Gujarat, and Madhya Pradesh etc. We also give gift samples to the companiesfor R&D purpose.

Iron sucrose is type II complex. Iron sucroseis widely used in the treatment of iron deficiency anaemia. And it is also usedin the treatment of chronic kidney disease. Iron sucrose comes in injectable formulation which is given by I.V. route.

SYNONYMS: Ferric hydroxide sucrosecomplex, Iron oxide saccharated, Iron saccharate, Iron sucrose, Iron sucrosecomplex, Iron sugar, Saccharated ferric oxide, Saccharated iron, Saccharatediron oxide, Sucroferric oxyhydroxide

IUPAC NAME:Pentairon(3+) ion disodium(2R,3R,4S,5S,6R)-2-{[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-trioltrihydrate hydroxide octaoxidandiide

CAS NO: 8047-67-4

FORMULA: C₁₂H₂₉Fe₅Na₂O₂₃

MOLECULAR MASS: 866.55 g/mol

STORAGE CONDITIONS: Store in cool and dry place. Donot put in bathroom or in kitchen. Keep away from children. Place away fromdirect light and heat.

HOW TO USE: Iron sucrose given by theinjection. Iron sucrose is given by I.V. route. Normally it is given slowly for2-5 minutes. It is also mixed with saline solution and given for longer time.The dose of the medicine depends on age, disease condition and treatmentresponse.

HOW IRON SUCROSE WORKS: After the I.V. administrationIron sucrose dissolves in to the blood stream and iron and sucrose willdissociate in blood. The iron will binds with the haemoglobin as cell maturesin red blood cells.

PHARMACOKINETICS OF IRON SUCROSE: Iron sucrose will absorbed inbody and reach the high serum levels after the I.V. administration. Ironsucrose only takes 10 minutes to reach the peak plasma concentration. Ironsucrose binds with transferring protein. The half-life of the Iron sucrose is 6hours. Less than 5% of Iron sucrose is eliminated from the body; the excretionof Iron sucrose is done by renal rout.

SIDE EFFECTS: The normal side effects of Ironsucrose are nausea, vomiting, muscle cramp, headache, joint pain, back pain,cough, constipation, swelling of legs and arms are normally seen in thepatients. Fainting and dizziness also seen some time after giving the dose. Seedoctor right away if you see side effects like chest pain, irregular heartbeat,pressure in chest, blurred vision or problem in breathing.

PRECAUTIONS: Tell your doctors if you have areallergic to Iron sucrose. Do not take medication if you are in pregnancy. Consultyour doctor before breast feeding because the medicine passes through thebreast milk.

CDSCO APPROVAL: Iron sucrose injection approvedby CDSCO in India in 25.03.2004

Iron sucrose complex inj. i.v (finished formulation) approved byCDSCO in India in 02.01.1999

FORMULATIONS AVAILABLE IN MARKET:

Iron sucrose 50 MG tablets

Iron sucrose 500 MG tablets

Iron sucrose injection

Note: Product protected by validpatents are not offered for sale in countries where such patents are stillvalid and its liability is at Buyers Risk

REFERENCES:

www.webmd.com

https://pubchem.ncbi.nlm.nih.gov

https://go.drugbank.com

https://cdscoonline.gov.in

https://www.wikipedia.org/

https://www.drugs.com

https://www.zaubacorp.com

https://www.practo.com/consult